PMID: 16534317Mar 15, 2006Paper

Statins in the prevention of perioperative cardiovascular complications

Current Opinion in Anaesthesiology
Olaf Schouten, Don Poldermans

Abstract

This is a review of recent experimental and clinical evidence for the use of perioperative statins to reduce cardiovascular complications. Clinical trials have demonstrated an improved survival of statin users in the perioperative period. This beneficial effect of statins is ascribed to the non-lipid lowering effect to stabilize vulnerable plaques, thereby preventing myocardial ischaemia and infarction. The proposed mechanism of this cardioprotective effect is by the anti-inflammatory properties of statins. The fear of adverse perioperative effects of statin use, i.e. rhabdomyolysis, has not been confirmed in clinical studies. The anti-inflammatory properties of statins appear to have an important effect on coronary plaque stabilization in the perioperative setting, resulting in a reduction in perioperative cardiovascular complications.

References

Dec 5, 1998·The New England Journal of Medicine·UNKNOWN Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
May 26, 1999·Cardiovascular Research·D E Gutstein, V Fuster
Mar 18, 2000·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·M C Cohen, T H Aretz
Mar 24, 2000·Atherosclerosis·A G ZamanJ J Badimon
Nov 10, 2001·Arteriosclerosis, Thrombosis, and Vascular Biology·M Takemoto, J K Liao
Nov 17, 2001·European Journal of Internal Medicine·P L van HaelstJ W Tervaert
Mar 6, 2002·Circulation·Peter LibbyAttilio Maseri
Aug 21, 2002·Circulation·Richard C PasternakUNKNOWN National Heart, Lung and Blood Institute
Nov 30, 2002·Lancet·James ShepherdUNKNOWN PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Jan 14, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Wolfgang DichtlFranz Weidinger
Mar 5, 2003·The American Journal of Cardiology·Peter Libby, Masanori Aikawa
Apr 4, 2003·JAMA : the Journal of the American Medical Association·Paul D ThompsonRichard H Karas
Jun 28, 2003·The American Journal of Medicine·Duminda N WijeysunderaW Scott Beattie
Oct 15, 2003·Archives of Internal Medicine·Miklos D KertaiUNKNOWN Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography (DECREASE) Study Group
Nov 26, 2003·Clinica Chimica Acta; International Journal of Clinical Chemistry·Zhu-mei XuHong-nian Zhou
Jan 13, 2004·The American Journal of Medicine·Miklos D KertaiDon Poldermans
Mar 10, 2004·The American Journal of Medicine·Robert S Rosenson
Apr 21, 2004·British Journal of Anaesthesia·H-J Priebe
Apr 28, 2004·Journal of Vascular Surgery·Anai E S DurazzoBruno Caramelli
May 6, 2004·JAMA : the Journal of the American Medical Association·Peter K LindenauerEvan M Benjamin
Jun 3, 2004·Circulation·Julian P J Halcox, John E Deanfield
Jun 9, 2004·Circulation·Antonella LombardoAttilio Maseri
Jun 12, 2004·Journal of Vascular Surgery·Thomas A AbbruzzeseMichael S Conte

❮ Previous
Next ❯

Citations

Nov 3, 2006·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Nader N Boushra, Muhammad Muntazar
May 10, 2011·Clinical Psychology Review·Ian J Mitchell, Anthony R Beech

❮ Previous
Next ❯

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.